Silk fibroin is a protein-based natural polymer. Due to its excellent mechanical properties, good biocompatibility and bioabsorbability, silk fibroin has always been a hot topic in biomedical materials and is widely used in tissue repair and regeneration, artificial organs, drug delivery. As a bioregenerative material, silk fibroin has low immunogenicity, can adhere to cells and guide growth. It can induce the production of autologous soft tissue and can eventually be completely degraded. The degradation time can also be controlled. It is also an ideal medical and aesthetic material.
The global Silk Fibroin Biomaterials market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global Silk Fibroin Biomaterials market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Silk Fibroin Biomaterials market size and forecasts, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
Global Silk Fibroin Biomaterials market size and forecasts by region and country, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
Global Silk Fibroin Biomaterials market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (kg), and average selling prices (US$/g), 2019-2030
Global Silk Fibroin Biomaterials market shares of main players, shipments in revenue ($ Million), sales quantity (kg), and ASP (US$/g), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Silk Fibroin Biomaterials
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Silk Fibroin Biomaterials market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sofregen Inc, Evolved By Nature, Cocoon Biotech, CPT Sutures, Kelisema Srl, Seidecos, SEIREN Co., Ltd., DSM, Croda, Jiangxi Silk Biotechnology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Silk Fibroin Biomaterials market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Medical Grade Raw Materials
Cosmetic Grade Raw Materials
Others
麻豆原创 segment by Application
Bone Nail Plate
Artificial Cartilage
Biomedicine (Film Dressings, Drug Carriers)
Cosmetic
Food Preservation
Fabric
Others
Major players covered
Sofregen Inc
Evolved By Nature
Cocoon Biotech
CPT Sutures
Kelisema Srl
Seidecos
SEIREN Co., Ltd.
DSM
Croda
Jiangxi Silk Biotechnology Co., Ltd.
Simatech Incorporation
Zhejiang Xingyue Biotechnology Co., Ltd.
Hubei Sailuo Biomaterials Co., Ltd.
Favorsun
Chinatiansi
Hangzhou Lin Ran Bio-tech Co.,Ltd
Haifan
Cathaya
Suhaobio
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Silk Fibroin Biomaterials product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Silk Fibroin Biomaterials, with price, sales quantity, revenue, and global market share of Silk Fibroin Biomaterials from 2019 to 2024.
Chapter 3, the Silk Fibroin Biomaterials competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Silk Fibroin Biomaterials breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Silk Fibroin Biomaterials market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Silk Fibroin Biomaterials.
Chapter 14 and 15, to describe Silk Fibroin Biomaterials sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Silk Fibroin Biomaterials Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Medical Grade Raw Materials
1.3.3 Cosmetic Grade Raw Materials
1.3.4 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Silk Fibroin Biomaterials Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Bone Nail Plate
1.4.3 Artificial Cartilage
1.4.4 Biomedicine (Film Dressings, Drug Carriers)
1.4.5 Cosmetic
1.4.6 Food Preservation
1.4.7 Fabric
1.4.8 Others
1.5 Global Silk Fibroin Biomaterials 麻豆原创 Size & Forecast
1.5.1 Global Silk Fibroin Biomaterials Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Silk Fibroin Biomaterials Sales Quantity (2019-2030)
1.5.3 Global Silk Fibroin Biomaterials Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Sofregen Inc
2.1.1 Sofregen Inc Details
2.1.2 Sofregen Inc Major Business
2.1.3 Sofregen Inc Silk Fibroin Biomaterials Product and Services
2.1.4 Sofregen Inc Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Sofregen Inc Recent Developments/Updates
2.2 Evolved By Nature
2.2.1 Evolved By Nature Details
2.2.2 Evolved By Nature Major Business
2.2.3 Evolved By Nature Silk Fibroin Biomaterials Product and Services
2.2.4 Evolved By Nature Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Evolved By Nature Recent Developments/Updates
2.3 Cocoon Biotech
2.3.1 Cocoon Biotech Details
2.3.2 Cocoon Biotech Major Business
2.3.3 Cocoon Biotech Silk Fibroin Biomaterials Product and Services
2.3.4 Cocoon Biotech Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Cocoon Biotech Recent Developments/Updates
2.4 CPT Sutures
2.4.1 CPT Sutures Details
2.4.2 CPT Sutures Major Business
2.4.3 CPT Sutures Silk Fibroin Biomaterials Product and Services
2.4.4 CPT Sutures Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 CPT Sutures Recent Developments/Updates
2.5 Kelisema Srl
2.5.1 Kelisema Srl Details
2.5.2 Kelisema Srl Major Business
2.5.3 Kelisema Srl Silk Fibroin Biomaterials Product and Services
2.5.4 Kelisema Srl Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Kelisema Srl Recent Developments/Updates
2.6 Seidecos
2.6.1 Seidecos Details
2.6.2 Seidecos Major Business
2.6.3 Seidecos Silk Fibroin Biomaterials Product and Services
2.6.4 Seidecos Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Seidecos Recent Developments/Updates
2.7 SEIREN Co., Ltd.
2.7.1 SEIREN Co., Ltd. Details
2.7.2 SEIREN Co., Ltd. Major Business
2.7.3 SEIREN Co., Ltd. Silk Fibroin Biomaterials Product and Services
2.7.4 SEIREN Co., Ltd. Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 SEIREN Co., Ltd. Recent Developments/Updates
2.8 DSM
2.8.1 DSM Details
2.8.2 DSM Major Business
2.8.3 DSM Silk Fibroin Biomaterials Product and Services
2.8.4 DSM Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 DSM Recent Developments/Updates
2.9 Croda
2.9.1 Croda Details
2.9.2 Croda Major Business
2.9.3 Croda Silk Fibroin Biomaterials Product and Services
2.9.4 Croda Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Croda Recent Developments/Updates
2.10 Jiangxi Silk Biotechnology Co., Ltd.
2.10.1 Jiangxi Silk Biotechnology Co., Ltd. Details
2.10.2 Jiangxi Silk Biotechnology Co., Ltd. Major Business
2.10.3 Jiangxi Silk Biotechnology Co., Ltd. Silk Fibroin Biomaterials Product and Services
2.10.4 Jiangxi Silk Biotechnology Co., Ltd. Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Jiangxi Silk Biotechnology Co., Ltd. Recent Developments/Updates
2.11 Simatech Incorporation
2.11.1 Simatech Incorporation Details
2.11.2 Simatech Incorporation Major Business
2.11.3 Simatech Incorporation Silk Fibroin Biomaterials Product and Services
2.11.4 Simatech Incorporation Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Simatech Incorporation Recent Developments/Updates
2.12 Zhejiang Xingyue Biotechnology Co., Ltd.
2.12.1 Zhejiang Xingyue Biotechnology Co., Ltd. Details
2.12.2 Zhejiang Xingyue Biotechnology Co., Ltd. Major Business
2.12.3 Zhejiang Xingyue Biotechnology Co., Ltd. Silk Fibroin Biomaterials Product and Services
2.12.4 Zhejiang Xingyue Biotechnology Co., Ltd. Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Zhejiang Xingyue Biotechnology Co., Ltd. Recent Developments/Updates
2.13 Hubei Sailuo Biomaterials Co., Ltd.
2.13.1 Hubei Sailuo Biomaterials Co., Ltd. Details
2.13.2 Hubei Sailuo Biomaterials Co., Ltd. Major Business
2.13.3 Hubei Sailuo Biomaterials Co., Ltd. Silk Fibroin Biomaterials Product and Services
2.13.4 Hubei Sailuo Biomaterials Co., Ltd. Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Hubei Sailuo Biomaterials Co., Ltd. Recent Developments/Updates
2.14 Favorsun
2.14.1 Favorsun Details
2.14.2 Favorsun Major Business
2.14.3 Favorsun Silk Fibroin Biomaterials Product and Services
2.14.4 Favorsun Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Favorsun Recent Developments/Updates
2.15 Chinatiansi
2.15.1 Chinatiansi Details
2.15.2 Chinatiansi Major Business
2.15.3 Chinatiansi Silk Fibroin Biomaterials Product and Services
2.15.4 Chinatiansi Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 Chinatiansi Recent Developments/Updates
2.16 Hangzhou Lin Ran Bio-tech Co.,Ltd
2.16.1 Hangzhou Lin Ran Bio-tech Co.,Ltd Details
2.16.2 Hangzhou Lin Ran Bio-tech Co.,Ltd Major Business
2.16.3 Hangzhou Lin Ran Bio-tech Co.,Ltd Silk Fibroin Biomaterials Product and Services
2.16.4 Hangzhou Lin Ran Bio-tech Co.,Ltd Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 Hangzhou Lin Ran Bio-tech Co.,Ltd Recent Developments/Updates
2.17 Haifan
2.17.1 Haifan Details
2.17.2 Haifan Major Business
2.17.3 Haifan Silk Fibroin Biomaterials Product and Services
2.17.4 Haifan Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Haifan Recent Developments/Updates
2.18 Cathaya
2.18.1 Cathaya Details
2.18.2 Cathaya Major Business
2.18.3 Cathaya Silk Fibroin Biomaterials Product and Services
2.18.4 Cathaya Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 Cathaya Recent Developments/Updates
2.19 Suhaobio
2.19.1 Suhaobio Details
2.19.2 Suhaobio Major Business
2.19.3 Suhaobio Silk Fibroin Biomaterials Product and Services
2.19.4 Suhaobio Silk Fibroin Biomaterials Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.19.5 Suhaobio Recent Developments/Updates
3 Competitive Environment: Silk Fibroin Biomaterials by Manufacturer
3.1 Global Silk Fibroin Biomaterials Sales Quantity by Manufacturer (2019-2024)
3.2 Global Silk Fibroin Biomaterials Revenue by Manufacturer (2019-2024)
3.3 Global Silk Fibroin Biomaterials Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Silk Fibroin Biomaterials by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Silk Fibroin Biomaterials Manufacturer 麻豆原创 Share in 2023
3.4.3 Top 6 Silk Fibroin Biomaterials Manufacturer 麻豆原创 Share in 2023
3.5 Silk Fibroin Biomaterials 麻豆原创: Overall Company Footprint Analysis
3.5.1 Silk Fibroin Biomaterials 麻豆原创: Region Footprint
3.5.2 Silk Fibroin Biomaterials 麻豆原创: Company Product Type Footprint
3.5.3 Silk Fibroin Biomaterials 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Silk Fibroin Biomaterials 麻豆原创 Size by Region
4.1.1 Global Silk Fibroin Biomaterials Sales Quantity by Region (2019-2030)
4.1.2 Global Silk Fibroin Biomaterials Consumption Value by Region (2019-2030)
4.1.3 Global Silk Fibroin Biomaterials Average Price by Region (2019-2030)
4.2 North America Silk Fibroin Biomaterials Consumption Value (2019-2030)
4.3 Europe Silk Fibroin Biomaterials Consumption Value (2019-2030)
4.4 Asia-Pacific Silk Fibroin Biomaterials Consumption Value (2019-2030)
4.5 South America Silk Fibroin Biomaterials Consumption Value (2019-2030)
4.6 Middle East & Africa Silk Fibroin Biomaterials Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Silk Fibroin Biomaterials Sales Quantity by Type (2019-2030)
5.2 Global Silk Fibroin Biomaterials Consumption Value by Type (2019-2030)
5.3 Global Silk Fibroin Biomaterials Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Silk Fibroin Biomaterials Sales Quantity by Application (2019-2030)
6.2 Global Silk Fibroin Biomaterials Consumption Value by Application (2019-2030)
6.3 Global Silk Fibroin Biomaterials Average Price by Application (2019-2030)
7 North America
7.1 North America Silk Fibroin Biomaterials Sales Quantity by Type (2019-2030)
7.2 North America Silk Fibroin Biomaterials Sales Quantity by Application (2019-2030)
7.3 North America Silk Fibroin Biomaterials 麻豆原创 Size by Country
7.3.1 North America Silk Fibroin Biomaterials Sales Quantity by Country (2019-2030)
7.3.2 North America Silk Fibroin Biomaterials Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Silk Fibroin Biomaterials Sales Quantity by Type (2019-2030)
8.2 Europe Silk Fibroin Biomaterials Sales Quantity by Application (2019-2030)
8.3 Europe Silk Fibroin Biomaterials 麻豆原创 Size by Country
8.3.1 Europe Silk Fibroin Biomaterials Sales Quantity by Country (2019-2030)
8.3.2 Europe Silk Fibroin Biomaterials Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Silk Fibroin Biomaterials Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Silk Fibroin Biomaterials Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Silk Fibroin Biomaterials 麻豆原创 Size by Region
9.3.1 Asia-Pacific Silk Fibroin Biomaterials Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Silk Fibroin Biomaterials Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 South Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Silk Fibroin Biomaterials Sales Quantity by Type (2019-2030)
10.2 South America Silk Fibroin Biomaterials Sales Quantity by Application (2019-2030)
10.3 South America Silk Fibroin Biomaterials 麻豆原创 Size by Country
10.3.1 South America Silk Fibroin Biomaterials Sales Quantity by Country (2019-2030)
10.3.2 South America Silk Fibroin Biomaterials Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Silk Fibroin Biomaterials Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Silk Fibroin Biomaterials Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Silk Fibroin Biomaterials 麻豆原创 Size by Country
11.3.1 Middle East & Africa Silk Fibroin Biomaterials Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Silk Fibroin Biomaterials Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Silk Fibroin Biomaterials 麻豆原创 Drivers
12.2 Silk Fibroin Biomaterials 麻豆原创 Restraints
12.3 Silk Fibroin Biomaterials Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Silk Fibroin Biomaterials and Key Manufacturers
13.2 Manufacturing Costs Percentage of Silk Fibroin Biomaterials
13.3 Silk Fibroin Biomaterials Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Silk Fibroin Biomaterials Typical Distributors
14.3 Silk Fibroin Biomaterials Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Sofregen Inc
Evolved By Nature
Cocoon Biotech
CPT Sutures
Kelisema Srl
Seidecos
SEIREN Co., Ltd.
DSM
Croda
Jiangxi Silk Biotechnology Co., Ltd.
Simatech Incorporation
Zhejiang Xingyue Biotechnology Co., Ltd.
Hubei Sailuo Biomaterials Co., Ltd.
Favorsun
Chinatiansi
Hangzhou Lin Ran Bio-tech Co.,Ltd
Haifan
Cathaya
Suhaobio
听
听
*If Applicable.
